My Bibliography

select

Schmit SL, Loroña NC, Sobieski D, Matejcic M, Nguyen NT, Hoehn HJ, Diaz DB, Shankar K, Cockman EM, Jean-Baptiste E, Tsai YY, Buchalter RB, Brito K, Wilson R, Coppola D, Fulmer C, Saglam O, Tassielli AF, Beato F, Dai R, Freedman JA, Purrington K, Hu B, Mcgrail D, Gibson H, Jiang K, Muñoz-Antonia T, Flores I, Gordian E, Oliveras Torres JA, Cheng I, Van Blarigan EL, Felder SI, Sanchez JA, Fleming JB, Siegel EM, Cress D, Thompson P, Stern MC, Teer JK, Figueiredo JC. Building research infrastructure to advance precision medicine in colorectal cancer. JNCI Cancer Spectr. 2025 Mar 20;. doi: 10.1093/jncics/pkaf027. [Epub ahead of print] PubMed PMID: 40111849.

select

Trendowski MR, Watza D, Lusk CM, Lonardo F, Ratliff V, Wenzlaff AS, Mamdani H, Neslund-Dudas C, Boerner JL, Schwartz AG, Gibson HM. Evaluation of the Immune Response within the Tumor Microenvironment in African American and Non-Hispanic White Patients with Non-Small Cell Lung Cancer. Cancer Epidemiol Biomarkers Prev. 2024 Sep 3;33(9):1220-1228. doi: 10.1158/1055-9965.EPI-24-0333. PubMed PMID: 38953893; PubMed Central PMCID: PMC11371519.

select

Hossain MM, King P, Hackett J, Gerard HC, Niwinski R, Wu L, Van Kaer L, Dyson G, Gibson H, Borowsky AD, Sebzda E. Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner. Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2404916121. doi: 10.1073/pnas.2404916121. Epub 2024 Aug 29. PubMed PMID: 39207730; PubMed Central PMCID: PMC11388331.

select

Denison M, Ullrich A, Herroon MK, Mecca S, Turro C, Podgorski I, Gibson H, Kodanko JJ. Ru(II)-Photoactive Agents for Targeting ER Stress and Immunogenic Cell Death. bioRxiv. 2024 Jul 22;. doi: 10.1101/2024.07.18.604104. PubMed PMID: 39091867; PubMed Central PMCID: PMC11291038.

select

Denison M, Garcia SP, Ullrich A, Podgorski I, Gibson H, Turro C, Kodanko JJ. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy. Inorg Chem. 2024 Apr 29;63(17):7973-7983. doi: 10.1021/acs.inorgchem.4c01008. Epub 2024 Apr 14. PubMed PMID: 38616353; PubMed Central PMCID: PMC11066580.

select

Hackett JB, Ramos N, Barr S, Bross M, Viola NT, Gibson HM. Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors. Front Oncol. 2023;13:1285117. doi: 10.3389/fonc.2023.1285117. eCollection 2023. PubMed PMID: 38130991; PubMed Central PMCID: PMC10735274.

select

Glassbrook JE, Hackett JB, Muñiz MC, Bross M, Dyson G, Movahhedin N, Ullrich A, Gibson HM. Host genetic background regulates the capacity for anti-tumor antibody-dependent phagocytosis. bioRxiv. 2023 May 9;. doi: 10.1101/2023.05.09.540046. PubMed PMID: 37214876; PubMed Central PMCID: PMC10197614.

select

Mitchell AV, Wu L, James Block C, Zhang M, Hackett J, Craig DB, Chen W, Zhao Y, Zhang B, Dang Y, Zhang X, Zhang S, Wang C, Gibson H, Pile LA, Kidder B, Matherly L, Yang Z, Dou Y, Wu G. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. Nat Commun. 2022 Nov 1;13(1):6548. doi: 10.1038/s41467-022-34239-z. PubMed PMID: 36319643; PubMed Central PMCID: PMC9626503.

select

Hackett J, Gibson H, Frelinger J, Buntzman A. Using the Collaborative Cross and Diversity Outbred Mice in Immunology. Curr Protoc. 2022 Sep;2(9):e547. doi: 10.1002/cpz1.547. PubMed PMID: 36066328; PubMed Central PMCID: PMC9612550.

select

Wallace-Povirk A, Rubinsak L, Malysa A, Dzinic SH, Ravindra M, Schneider M, Glassbrook J, O'Connor C, Hou Z, Kim S, Back J, Polin L, Morris RT, Gangjee A, Gibson H, Matherly LH. Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment. Sci Rep. 2022 Jul 5;12(1):11346. doi: 10.1038/s41598-022-14788-5. PubMed PMID: 35790779; PubMed Central PMCID: PMC9256750.

select

Viola NT, Glassbrook JE, Kalluri JR, Hackett JB, Wicker MN, Sternberg J, Gibson HM. Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses. Front Immunol. 2022;13:870110. doi: 10.3389/fimmu.2022.870110. eCollection 2022. PubMed PMID: 35634303; PubMed Central PMCID: PMC9130849.

select

Toupin N, Herroon MK, Thummel RP, Turro C, Podgorski I, Gibson H, Kodanko JJ. Metalloimmunotherapy with Rhodium and Ruthenium Complexes: Targeting Tumor-Associated Macrophages. Chemistry. 2022 Apr 27;28(24):e202104430. doi: 10.1002/chem.202104430. Epub 2022 Mar 24. PubMed PMID: 35235227; PubMed Central PMCID: PMC9541094.

select

Hackett JB, Glassbrook JE, Muñiz MC, Bross M, Fielder A, Dyson G, Movahhedin N, McCasland J, McCarthy-Leo C, Gibson HM. A diversity outbred F1 mouse model identifies host-intrinsic genetic regulators of response to immune checkpoint inhibitors. Oncoimmunology. 2022;11(1):2064958. doi: 10.1080/2162402X.2022.2064958. eCollection 2022. PubMed PMID: 35481286; PubMed Central PMCID: PMC9037414.

select

Block CJ, Mitchell AV, Wu L, Glassbrook J, Craig D, Chen W, Dyson G, DeGracia D, Polin L, Ratnam M, Gibson H, Wu G. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA. Oncogene. 2021 Nov;40(46):6430-6442. doi: 10.1038/s41388-021-02030-x. Epub 2021 Oct 4. PubMed PMID: 34608266; PubMed Central PMCID: PMC9421946.

select

Wei WZ, Gibson HM, Jacob JB, Frelinger JA, Berzofsky JA, Maeng H, Dyson G, Reyes JD, Pilon-Thomas S, Ratner S, Wei KC. Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity. J Immunol. 2020 Sep 15;205(6):1554-1563. doi: 10.4049/jimmunol.2000466. Epub 2020 Aug 12. PubMed PMID: 32796024; PubMed Central PMCID: PMC7484363.

select

McCarthy CE, White JM, Viola NT, Gibson HM. In vivo Imaging Technologies to Monitor the Immune System. Front Immunol. 2020;11:1067. doi: 10.3389/fimmu.2020.01067. eCollection 2020. Review. PubMed PMID: 32582173; PubMed Central PMCID: PMC7280489.

select

White JM, Keinänen OM, Cook BE, Zeglis BM, Gibson HM, Viola NT. Removal of Fc Glycans from [(89)Zr]Zr-DFO-Anti-CD8 Prevents Peripheral Depletion of CD8(+) T Cells. Mol Pharm. 2020 Jun 1;17(6):2099-2108. doi: 10.1021/acs.molpharmaceut.0c00270. Epub 2020 May 12. PubMed PMID: 32330387; PubMed Central PMCID: PMC7307332.

select

Jones RF, Reyes JD, Gibson HM, Jacob JB, Vaishampayan U, Ratner S, Chen K, Wei WZ. An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice. Cancer Immunol Immunother. 2019 Jul;68(7):1143-1155. doi: 10.1007/s00262-019-02333-9. Epub 2019 Jun 8. PubMed PMID: 31177328; PubMed Central PMCID: PMC6586491.

select

Gibson HM, Viola NT. The importance of examining an active immune system during immunotherapy. Oncotarget. 2019 Jan 15;10(5):559-560. doi: 10.18632/oncotarget.26580. eCollection 2019 Jan 15. PubMed PMID: 30728906; PubMed Central PMCID: PMC6355172.

select

Gibson HM, McKnight BN, Malysa A, Dyson G, Wiesend WN, McCarthy CE, Reyes J, Wei WZ, Viola-Villegas NT. IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy. Cancer Res. 2018 Oct 1;78(19):5706-5717. doi: 10.1158/0008-5472.CAN-18-0253. Epub 2018 Aug 16. PubMed PMID: 30115693; PubMed Central PMCID: PMC6443251.

select

Wei WZ, Jones RF, Juhasz C, Gibson H, Veenstra J. Evolution of animal models in cancer vaccine development. Vaccine. 2015 Dec 16;33(51):7401-7407. doi: 10.1016/j.vaccine.2015.07.075. Epub 2015 Aug 1. Review. PubMed PMID: 26241945; PubMed Central PMCID: PMC4684455.

select

Wong HK, Gibson H, Hake T, Geyer S, Frederickson J, Marcucci G, Caligiuri MA, Porcu P, Mishra A. Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome. J Invest Dermatol. 2015 Aug;135(8):2084-2092. doi: 10.1038/jid.2015.116. Epub 2015 Mar 25. PubMed PMID: 25806852.

select

Gibson HM, Veenstra JJ, Jones R, Vaishampayan U, Sauerbrey M, Bepler G, Lum L, Reyes J, Weise A, Wei WZ. Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination. Cancer Immunol Res. 2015 Jul;3(7):777-86. doi: 10.1158/2326-6066.CIR-14-0175. Epub 2015 Feb 23. PubMed PMID: 25711535; PubMed Central PMCID: PMC4491035.

select

Veenstra JJ, Gibson HM, Freytag S, Littrup PJ, Wei WZ. In situ immunization via non-surgical ablation to prevent local and distant tumor recurrence. Oncoimmunology. 2015 Mar;4(3):e989762. doi: 10.4161/2162402X.2014.989762. eCollection 2015 Mar. PubMed PMID: 25949901; PubMed Central PMCID: PMC4404795.

select

Gibson H, Munns S, Freytag S, Barton K, Veenstra J, Bettahi I, Bissonette J, Wei WZ. Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors. Oncoimmunology. 2015 Jan;4(1):e984523. doi: 10.4161/2162402X.2014.984523. eCollection 2015 Jan. PubMed PMID: 25949865; PubMed Central PMCID: PMC4368120.

select

Zou Y, Xie L, Carroll S, Muniz M, Gibson H, Wei WZ, Liu H, Mao G. Layer-by-layer films with bioreducible and nonbioreducible polycations for sequential DNA release. Biomacromolecules. 2014 Nov 10;15(11):3965-75. doi: 10.1021/bm5010433. Epub 2014 Oct 31. PubMed PMID: 25360688.

select

Veenstra JJ, Gibson HM, Littrup PJ, Reyes JD, Cher ML, Takashima A, Wei WZ. Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity. Cancer Res. 2014 Oct 1;74(19):5409-20. doi: 10.1158/0008-5472.CAN-14-0501. Epub 2014 Aug 4. PubMed PMID: 25092895; PubMed Central PMCID: PMC4185007.

select

Chan DV, Gibson HM, Aufiero BM, Wilson AJ, Hafner MS, Mi QS, Wong HK. Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation. Genes Immun. 2014 Jan;15(1):25-32. doi: 10.1038/gene.2013.57. Epub 2013 Oct 31. PubMed PMID: 24173147; PubMed Central PMCID: PMC4284071.

select

Gibson HM, Mishra A, Chan DV, Hake TS, Porcu P, Wong HK. Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome. J Invest Dermatol. 2013 Jan;133(1):249-57. doi: 10.1038/jid.2012.265. Epub 2012 Sep 6. PubMed PMID: 22951729; PubMed Central PMCID: PMC4284066.

select

Piechocki MP, Wu GS, Jones RF, Jacob JB, Gibson H, Ethier SP, Abrams J, Yagita H, Venuprasad K, Wei WZ. Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. Int J Cancer. 2012 Dec 1;131(11):2562-72. doi: 10.1002/ijc.27534. Epub 2012 Apr 24. PubMed PMID: 22419388; PubMed Central PMCID: PMC3387508.

select

Tang N, Gibson H, Germeroth T, Porcu P, Lim HW, Wong HK. T-plastin (PLS3) gene expression differentiates Sézary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression. Br J Dermatol. 2010 Feb 1;162(2):463-6. doi: 10.1111/j.1365-2133.2009.09587.x. Epub 2009 Nov 30. PubMed PMID: 19995369; PubMed Central PMCID: PMC3928081.

select

Chong BF, Wilson AJ, Gibson HM, Hafner MS, Luo Y, Hedgcock CJ, Wong HK. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides. Clin Cancer Res. 2008 Feb 1;14(3):646-53. doi: 10.1158/1078-0432.CCR-07-0610. PubMed PMID: 18245523; PubMed Central PMCID: PMC4309376.

select

Gibson HM, Hedgcock CJ, Aufiero BM, Wilson AJ, Hafner MS, Tsokos GC, Wong HK. Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter. J Immunol. 2007 Sep 15;179(6):3831-40. doi: 10.4049/jimmunol.179.6.3831. PubMed PMID: 17785820; PubMed Central PMCID: PMC4290020.

select

Wong HK, Wilson AJ, Gibson HM, Hafner MS, Hedgcock CJ, Berger CL, Edelson RL, Lim HW. Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphoma. J Invest Dermatol. 2006 Jan;126(1):212-9. doi: 10.1038/sj.jid.5700029. PubMed PMID: 16417239.